We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AXM Pharma Inc (CE) | USOTC:AXMP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
1.
|
Names
of Reporting Persons.
|
Enable
Capital Management, LLC
|
|||||
2.
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
(a)
£
(b)
£
|
|||||
3.
|
SEC
Use Only
|
||||||
4.
|
Citizenship
or Place of Organization
|
Delaware
|
|||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5.
|
Sole
Voting Power
|
1,185,202
|
||||
6.
|
Shared
Voting Power
|
0
|
|||||
7.
|
Sole
Dispositive Power
|
1,185,202
|
|||||
8.
|
Shared
Dispositive Power
|
0
|
|||||
9.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
1,185,202
|
|||||
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
£
|
|||||
11.
|
Percent
of Class Represented by Amount in Row (9)
|
5.3%
|
|||||
12.
|
Type
of Reporting Person (See Instructions)
|
OO
|
1.
|
Names
of Reporting Persons.
|
Mitchell
S. Levine
|
||||
2.
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
(a)
£
(b)
£
|
||||
3.
|
SEC
Use Only
|
|||||
4.
|
Citizenship
or Place of Organization
|
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5.
|
Sole
Voting Power
|
1,185,202
|
|||
6.
|
Shared
Voting Power
|
0
|
||||
7.
|
Sole
Dispositive Power
|
1,185,202
|
||||
8.
|
Shared
Dispositive Power
|
0
|
||||
9.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
1,185,202
|
||||
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
£
|
||||
11.
|
Percent
of Class Represented by Amount in Row (9)
|
5.3%
|
||||
12.
|
Type
of Reporting Person (See Instructions)
|
IN
|
Item
1(a).
|
Name
of Issuer:
|
Item
1(b).
|
Address
of Issuer’s Principal Executive
Offices:
|
Item
2(a).
|
Names
of Persons Filing:
|
Item
2(b).
|
Address
of Principal Business Office or, if none,
Residence:
|
Item
2(c).
|
Citizenship:
|
Item
2(d).
|
Title
of Class of Securities:
|
Item
2(e).
|
CUSIP
Number:
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
check whether the person filing is
a:
|
Item
4.
|
Ownership.
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person.
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security
Being
Reported on By the Parent Holding
Company
|
Item
8.
|
Identification
and Classification of Members of the
Group
|
Item
9.
|
Notice
of Dissolution of Group
|
Item
10.
|
Certification
|
Dated: August
4, 2008
|
ENABLE
CAPITAL MANAGEMENT, LLC
By:
/s/ Mitchell
S.
Levine
Mitchell
S. Levine, its Managing Member
|
MITCHELL
S. LEVINE
/s/
Mitchell S.
Levine
Mitchell
S. Levine
|
Exhibit A
|
Joint
Filing Undertaking
|
Page
8
|
Dated: August
4, 2008
|
ENABLE
CAPITAL MANAGEMENT, LLC
By:
/s/ Mitchell
S.
Levine
Mitchell
S. Levine, its Managing Member
|
MITCHELL
S. LEVINE
/s/
Mitchell S.
Levine
Mitchell
S. Levine
|
1 Year AXM Pharma (CE) Chart |
1 Month AXM Pharma (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions